ARX:ASX
Aroa Biosurgery Ltd
A$0.50
arrow_downward
-0.98%(-0.0050) 1D
Sep 28, 1:47:53 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.51
Low
A$0.50
Mkt. cap
174.68M
Avg. vol.
129.97K
Volume
98.88K
P/E ratio
48.60
52-wk high
A$0.80
52-wk low
A$0.50
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.51
Low
A$0.50
Mkt. cap
174.68M
Avg. vol.
129.97K
Volume
98.88K
P/E ratio
48.60
52-wk high
A$0.80
52-wk low
A$0.50
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd